msadmin
Boehringer Ingelheim taps Immunai AI platform in $15 million deal
Boehringer Ingelheim pays $15M for Immunai's AI platform to find shared T-cell targets across cancer and autoimmune disease.
New Zealand health system partners with NHS for AI scribe rollout
Te Whatu Ora partners with UCLPartners to gain evidence and confidence for AI scribe deployment across emergency departments.
Singapore launches national programme for foundation AI in healthcare
Singapore's SIMFONI programme will build foundation AI models for cardiometabolic care and eye disease, embedded into the national EMR system.
DeepMind unveils AI co-clinician research for triadic care model
Google DeepMind introduces the AI co-clinician initiative, envisioning AI agents that collaborate with physicians under clinical authority to deliver more…
Mount Sinai AI model maps how genes function together in cells
Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…
Over 173 AI-designed drugs now in trials as FDA decision nears
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…
Kordata launches AI platform for neural-guided clinical trials
Kordata Dynamics emerges from stealth with an AI platform that processes neural data to accelerate and improve precision clinical trials…
Hemispheric raises $52M for AI brain foundation model
NeuroAI startup Hemispheric raised $52M for Descartes, a 6-billion-parameter brain foundation model trained on over 250,000 hours of EEG data.